Replies to post #140504 on Biotech Values

[DewDiligence]

One would expect there would be further chance of relapse in HCV DAA combo trials that exclude ribavirin…

Perhaps, but it depends on the constituent drugs in the cocktail. For some combinations, ribavirin may prove to be superfluous.